Home » Stocks » NTRA

Natera, Inc. (NTRA)

Stock Price: $119.66 USD 4.70 (4.09%)
Updated Jun 24, 2021 2:27 PM EDT - Market open
Market Cap 10.21B
Revenue (ttm) 449.31M
Net Income (ttm) -258.23M
Shares Out 87.94M
EPS (ttm) -3.11
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day June 24
Last Price $119.66
Previous Close $114.96
Change ($) 4.70
Change (%) 4.09%
Day's Open 115.25
Day's Range 115.25 - 119.90
Day's Volume 1,023,230
52-Week Range 44.57 - 127.19

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

AUSTIN, Texas and SHENZHEN, China, June 24, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA (cfDNA) testing, and  BGI Genomics Co., Ltd. , (300676.SZ), one...

5 hours ago - PRNewsWire

AUSTIN, Texas, June 18, 2021 /PRNewswire/ --  Natera,Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that the Centers for Medicare & Medicaid Services (CMS) ha...

6 days ago - PRNewsWire

AUSTIN, Texas, June 16, 2021 /PRNewswire/ -- Natera,Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced the publication of a new study in Nature, validating the ab...

1 week ago - PRNewsWire

CAMBRIDGE, Mass. and AUSTIN, Texas, June 8, 2021 /PRNewswire/ -- Foundation Medicine, Inc. and Natera, Inc. (NASDAQ: NTRA), today announced the launch of the research use version of FoundationOne®Tracke...

2 weeks ago - PRNewsWire

AUSTIN, Texas, June 4, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA (cfDNA) testing, today announced it will present new data on its latest scientific i...

2 weeks ago - PRNewsWire

Naturally Splendid Enterprises Ltd (FRA:50N) (CVE:NSP) (OTCPINK:NSPDF) has reported its first-quarter results, revealing a narrowing loss compared to the same period of 2020. The company's net loss was ...

3 weeks ago - Proactive Investors

AUSTIN, Texas, May 28, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA (cfDNA) testing, today announced it has been sued by Guardant Health, in an attempt ...

3 weeks ago - PRNewsWire

AUSTIN, Texas, May 26, 2021 /PRNewswire/ --  Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will present new clinical data on its personalized and ...

4 weeks ago - PRNewsWire

AUSTIN, Texas, May 20, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced initial results from the CIRCULATE-Japan trial, the largest...

1 month ago - PRNewsWire

Natera (NTRA) delivered earnings and revenue surprises of 29.52% and 31.68%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Shares of Natera (NASDAQ:NTRA) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 64.44% over the past year to ($0.74), which beat the estimate...

1 month ago - Benzinga

AUSTIN, Texas, May 6, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ:  NTRA), a pioneer and global leader in cell-free DNA testing, today reported financial results for the first quarter ended March 31, 2021...

1 month ago - PRNewsWire

AUSTIN, Texas, May 3, 2021 /PRNewswire/ --  Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will present 4 posters at the 2021 American Society of C...

1 month ago - PRNewsWire

Naturally Splendid Enterprises Ltd (CVE:NSP) (OTCPINK:NSPDF) (FRA:50N) has appointed CANEX Foods as master distributor for NATERA Plant Based Foods in Canada.  Previously, CANEX Foods was a distributor ...

1 month ago - Proactive Investors

AUSTIN, Texas, April 29, 2021 /PRNewswire/ --  Natera, Inc.  (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will release results for its first quarter ende...

1 month ago - PRNewsWire

Natera (NTRA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

Naturally Splendid Enterprises Ltd (CVE:NSP) (OTCPINK:NSPDF) (FRA:50N) has announced that the third shipping container of Natera Plant Based Foods has arrived from Australia.  In anticipation of demand ...

2 months ago - Proactive Investors

Naturally Splendid Enterprises Ltd (CVE:NSP) (OTCPINK:NSPDF) (FRA:50N) has announced that the third shipping container of Natera Plant Based Foods has arrived from Australia.  In anticipation of demand ...

2 months ago - Proactive Investors

AUSTIN, Texas, April 22, 2021 /PRNewswire/ --  Natera, Inc.  (NASDAQ: NTRA), a pioneer and a global leader in cell-free DNA testing, receives pathway to future coverage for the Prospera donor-derived, c...

2 months ago - PRNewsWire

The stock price of Natera, a clinical genetic testing company, has seen a large 14% drop in just five trading sessions. The decline is driven in part by the broader sell-off in high growth stocks, and p...

2 months ago - Forbes

AUSTIN, Texas, April 7, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, has implemented the first wave of Panorama AI innovations following the br...

2 months ago - PRNewsWire

These under-the-radar stocks have had incredible growth over the last 5 years, and are all off over 15% from their highs.

Other stocks mentioned: CDNA, VCYT
2 months ago - The Motley Fool

AUSTIN, Texas, March 31, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in non-invasive genetic testing and analysis of cfDNA, and Tesis Labs, a US multi-region lab servic...

2 months ago - PRNewsWire

AUSTIN, Texas, March 24, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that the US Food and Drug Administration (FDA) has grante...

3 months ago - PRNewsWire

AUSTIN, Texas, March 10, 2021 /PRNewswire/ --  Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that the first patient has been screened in a new phase ...

3 months ago - PRNewsWire

Naturally Splendid Enterprises Ltd (CVE:NSP) (OTCPINK:NSPDF) (FRA:50N), a supplier of vegetarian meat substitutes, sports and energy bars, and hemp-based products, has appealed the Federal Court of Cana...

3 months ago - Proactive Investors

Shares of Natera (NASDAQ:NTRA) rose in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share fell 93.48% year over year to ($0.89), which missed the estimate o...

3 months ago - Benzinga

Natera (NTRA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

4 months ago - Zacks Investment Research

Natera (NTRA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

4 months ago - Zacks Investment Research

MENLO PARK, Calif. & SAN CARLOS, Calif.--(BUSINESS WIRE)---- $NTRA #PrecisionOncology--Natera and Personalis Partner for Personalized Monitoring in Oncology

4 months ago - Business Wire

Some medical stocks gained momentum because of the pandemic, while others focus on high-reward challenges like cancer treatment. The post 7 Healthy Medical Stocks to Buy appeared first on InvestorPlace.

Other stocks mentioned: AMED, CRDF, FLGT, GHSI, OMI, TDOC
4 months ago - InvestorPlace

SAN CARLOS, Calif., Feb. 3, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cfDNA testing, presented key results from its SMART study at the SMFM 41st Annual Pregnancy M...

4 months ago - PRNewsWire

SAN CARLOS, Calif., Jan. 20, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, filed a lawsuit today against Inivata, Ltd. and its wholly-owned subs...

5 months ago - PRNewsWire

SAN CARLOS, Calif., Jan. 14, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA (cfDNA) testing, today announced it will present new data on the Prospera test...

5 months ago - PRNewsWire

SAN CARLOS, Calif., Jan. 12, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will present new data on its personalized and tumo...

5 months ago - PRNewsWire

These winners are positioned for gains even after COVID.

Other stocks mentioned: FLGT, GNMK, AWH, CODX
5 months ago - The Motley Fool

SAN CARLOS, Calif., Jan. 5, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will webcast a live presentation at the 39th A...

5 months ago - PRNewsWire

SAN CARLOS, Calif., Dec. 18, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA (cfDNA) testing, is pleased that the United States Patent Office granted Nater...

6 months ago - PRNewsWire

Increased adoption and expansion of products resulting in significant rises in volume. Producing meaningful improvements in revenues and costs per unit.

6 months ago - Seeking Alpha

SAN CARLOS, Calif., Dec. 1, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that the largest health plan in the United States has ...

6 months ago - PRNewsWire

SAN CARLOS, Calif., Nov. 30, 2020 /PRNewswire/ -- Natera,Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced a new paper published in Annals of Oncology, highlight...

6 months ago - PRNewsWire

Multiple companies are working on next-gen blood biopsies tech to detect cancer. The potential market size is big according to most estimates and analysts.

Other stocks mentioned: EXAS, GH, ILMN, PSNL
7 months ago - Seeking Alpha

SAN CARLOS, Calif., Nov. 12, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will webcast a live presentation at the Canaccord ...

7 months ago - PRNewsWire

In this article we will take a look at whether hedge funds think Natera Inc (NASDAQ:NTRA) is a good investment right now. We check hedge fund and billionaire investor sentiment before delving into hours...

7 months ago - Insider Monkey

SAN CARLOS, Calif., Nov. 10, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will present new immunotherapy data on its persona...

7 months ago - PRNewsWire

Natera, Inc. (NTRA) CEO Steve Chapman on Q3 2020 Results - Earnings Call Transcript

7 months ago - Seeking Alpha

Natera (NTRA) delivered earnings and revenue surprises of -7.46% and 11.71%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

7 months ago - Zacks Investment Research

SAN CARLOS, Calif., Oct. 30, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA (cfDNA) testing, applauds the recent International Society for Prenatal Diagno...

7 months ago - PRNewsWire

SAN CARLOS, Calif., Oct. 28, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will release results for its third quarter en...

7 months ago - PRNewsWire

SAN CARLOS, Calif., Oct. 29, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that a major health plan has extended coverage for no...

7 months ago - PRNewsWire

About NTRA

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; and Spectrum to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fert... [Read more...]

Industry
Diagnostics & Research
IPO Date
Jul 2, 2015
Stock Exchange
NASDAQ
Ticker Symbol
NTRA
Full Company Profile

Financial Performance

In 2020, Natera's revenue was $391.01 million, an increase of 29.33% compared to the previous year's $302.33 million. Losses were -$229.74 million, 84.0% more than in 2019.

Financial Statements

Analyst Forecasts

According to 9 analysts, the average rating for Natera stock is "Strong Buy." The 12-month stock price forecast is 137.00, which is an increase of 14.49% from the latest price.

Price Target
$137.00
(14.49% upside)
Analyst Consensus: Strong Buy